Details

Autor(en) / Beteiligte

• Walker, Jamie M
• Richardson, Timothy E
• Farrell, Kurt
• Iida, Megan A
• Foong, Chan
• Shang, Ping
• Attems, Johannes
• Ayalon, Gai
• Beach, Thomas G
• Bigio, Eileen H
• Budson, Andrew
• Cairns, Nigel J
• Corrada, María
• Cortes, Etty
• Dickson, Dennis W
• Fischer, Peter
• Flanagan, Margaret E
• Franklin, Erin
• Gearing, Marla
• Glass, Jonathan
• Hansen, Lawrence A
• Haroutunian, Vahram
• Hof, Patrick R
• Honig, Lawrence
• Kawas, Claudia
• Keene, C Dirk
• Kofler, Julia
• Kovacs, Gabor G
• Lee, Edward B
• Lutz, Mirjam I
• Mao, Qinwen
• Masliah, Eliezer
• McKee, Ann C
• McMillan, Corey T
• Mesulam, M Marsel
• Murray, Melissa
• Nelson, Peter T
• Perrin, Richard
• Pham, Thao
• Poon, Wayne
• Purohit, Dushyant P
• Rissman, Robert A
• Sakai, Kenji
• Sano, Mary
• Schneider, Julie A
• Stein, Thor D
• Teich, Andrew F
• Trojanowski, John Q
• Troncoso, Juan C
• Vonsattel, Jean-Paul
• Weintraub, Sandra
• Wolk, David A
• Woltjer, Randall L
• Yamada, Masahito
• Yu, Lei
• White, Charles L
• Crary, John F

Titel

Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy

Ist Teil von

• Journal of neuropathology and experimental neurology, 2021-02, Vol.80 (2), p.102-111

Ort / Verlag

England: Oxford University Press

Erscheinungsjahr

2021

Quelle

Oxford Journals 2020 Medicine

Beschreibungen/Notizen

• Abstract Primary age-related tauopathy (PART) is a neurodegenerative entity defined as Alzheimer-type neurofibrillary degeneration primarily affecting the medial temporal lobe with minimal to absent amyloid-β (Aβ) plaque deposition. The extent to which PART can be differentiated pathoanatomically from Alzheimer disease (AD) is unclear. Here, we examined the regional distribution of tau pathology in a large cohort of postmortem brains (n = 914). We found an early vulnerability of the CA2 subregion of the hippocampus to neurofibrillary degeneration in PART, and semiquantitative assessment of neurofibrillary degeneration in CA2 was significantly greater than in CA1 in PART. In contrast, subjects harboring intermediate-to-high AD neuropathologic change (ADNC) displayed relative sparing of CA2 until later stages of their disease course. In addition, the CA2/CA1 ratio of neurofibrillary degeneration in PART was significantly higher than in subjects with intermediate-to-high ADNC burden. Furthermore, the distribution of tau pathology in PART diverges from the Braak NFT staging system and Braak stage does not correlate with cognitive function in PART as it does in individuals with intermediate-to-high ADNC. These findings highlight the need for a better understanding of the contribution of PART to cognitive impairment and how neurofibrillary degeneration interacts with Aβ pathology in AD and PART.